COVID-19 pandemic and breast cancer management: An observational clinical study from Pakistan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023807

Enrollment

112

Registered

2020-12-10

Start date

2020-03-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 C50

Interventions

Group 1: Patients with Breast cancer presented from March 15 2020 to July 30 20220 were tested for COVID-19 subsequently data was collected on Proforma.

Eligibility

Sex/Gender

All

Age

23 Years to 72 Years

Inclusion criteria

Inclusion criteria: All Breast cancer patients who presented to Breast Clinic from 15th March to 31st July 2020 which either underwent surgery or referred for Neoadjuvant treatment were included.

Exclusion criteria

Exclusion criteria: Those patients with incomplete medical records or lost to follow-up were excluded from the analysis

Design outcomes

Primary

Measure	Time frame
COVID 19 Infectivity and associated complications in breast cancer cases.	—

Secondary

Measure	Time frame
Overall outcome of breast cancer patients	—

Countries

Pakistan

Contacts

Public ContactNarmeen Asif

Aga Khan University

narmeen.asif@aku.edu0092322281056

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026